Published Jan 2, 2025
From Biotech to Asset Management with Sunaina Sinha
Sunaina Sinha discusses her transition from biotech to asset management, emphasizing mentorship, strategic partnerships, and the intricacies of private equity investing, while dissecting valuation disparities between public and private markets and the evolving significance of liquidity mechanisms.

Topics covered
Popular Clips
Questions from this episode
- Asked by 12 people
- Asked by 9 people
- Asked by 7 people
- Asked by 5 people
- Asked by 4 people
- Asked by 4 people
- Asked by 4 people
- Asked by 3 people
- Asked by 3 people
- Asked by 3 people
- Asked by 3 people
- Asked by 3 people
Episode Highlights
Related Episodes
Savita Subramanian on Equity and Quantitative Strategy
Answers 383 questionsFrom Managing Portfolios to Running an Organization with Mike Freno
Answers 383 questionsRajiv Jain Discusses Portfolio Management
Answers 383 questionsGoldman Sachs Ashish Shah on Reading the Market With AI and Technology
Answers 383 questionsJulian C. Salisbury on Managing Global Assets
Answers 383 questionsHarin de Silva on Portfolio Management (Podcast)
Answers 383 questionsFrom Equity Research to International Investing With Heather Brilliant
Answers 383 questionsBruce Van Saun Shares Banking-Industry Insights
Answers 383 questionsMichael Carmen on Late-Stage Venture Capital and IPOs
Answers 383 questionsJason Schwarz Discusses Asset Management (Podcast)
Answers 383 questionsIlana Weinstein on the War for Talent at Hedge Funds
Answers 383 questionsFinding Overlooked Private Investments
Answers 383 questionsFrom Technology in Focus to Finance with Tony Kim
Answers 383 questionsMichael Fisch on Private Equity Funds
Answers 383 questionsChamath Palihapitiya on Venture Investments (Podcast)
Answers 383 questions